BOS Better Online Solutions (BOSC) Soared on Q3 Results, Gogo Inc. (GOGO) on Supplemental Type Certificate
Shares of B.O.S. Better Online Solutions Ltd. (BOSC) skyrocketed after the company reported its financial results, which reflect a continuing improvement in the Company's performance and financial position.
For the third quarter 2013, BOSC posted net profit of $219,000, compared to a net loss of $66,000 in the same period the prior year, and EBITDA of $495,000, compared to $175,000 in the third quarter 2012.
Cubist (CBST) and Ariad (ARIA) Epidemic Upward Path on Trading Session
The price of Cubist Pharmaceuticals Inc. (CBST) stock jumped $5.26 (or +8.03%) to $70.76 after the company reported positive top-line results from pivotal Phase 3 clinical trial of its antibiotic candidate ceftolozane/tazobactam in complicated urinary tract infections.
Johnson & Johnson (JNJ) Green Light for Its Chronic Hepatitis C Pill
- General Market News, Johnson & Johnson, JNJ, NYSE:JNJ, OLYSIO, chronic hepatitis C, compensated liver disease, genotype 1 chronic hepatitis C, Janssen Ireland, Janssen-Cilag International NV, Medivir, NS3/4A protease inhibitor, Peginterferon alfa-2a, pegylated interferon, Simeprevir, treatment-naïve, USFDA, antiviral treatment regimen, ribavirin, viral protease enzyme, sustained virologic response, Crown Equity Holdings, CRWE, OTCMKTS:CRWE, online b2b, iB2B Global
Green Mountain Coffee (GMCR) Soars on Results, Medidata (MDSO) on Long-Term Revenue Growth Target
CombiMatrix (CBMX) Skyrockets on Contract, Oncolytics (ONCY) Positive Data on REOLYSIN
CombiMatrix Corporation (Nasdaq:CBMX)
Shares of CBMX soared on Thursday's trading session after the company reported that it has entered into a contractual agreement with America's Choice Provider Network(R) (ACPN(R)) for coverage of its diagnostic laboratory services.
- General Market News, Oncolytics, NASDAQ:ONCY, ONCY, REOLYSIN, head and neck cancers, squamous cell carcinomas, oncolytic viruses, cancer therapeutics, CombiMatrix, NASDAQ:CBMX, CBMX, america's choice provider network, genetic abnormalities detection, Crown Equity Holdings, CRWE, crwetube, iB2B Global, online b2b, online video-sharing, OTCMKTS:CRWE
CFTC Silver Probe: See-no-Evil, Hear-no-Evil, Speak-no-Evil
When the world’s largest commodity futures “regulator” releases the results of a five-year probe; one expects to see a detailed, thorough, and well-reasoned analysis. What we see instead is a pathetic exercise in pseudo-logic – which could have been written in its entirety in a single afternoon. “Shallow” cannot begin to describe the lack of depth in this probe.